Ticker Symbol: CDTX
Cidara Therapeutics Inc
$1.68 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001610618
Company Profile
Cidara Therapeutics Inc. isa is developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections. The Company's portfolio is comprised of its lead antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) for the prevention and treatment of influenza and other viral diseases from Cidara's proprietary Cloudbreak® antiviral platform. Cidara is headquartered in San Diego, California.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 6310 Nancy Ridge Dr Ste 101
Website: www.cidara.com
CEO: Jeffrey Stein
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.85
Change:
-$0.01
(
-2.22%)
Days Range: $0.85 - $0.91
Beta: -
52wk. High: $2.10
52wk. Low: $0.46
Ytd. Change 13.53%
50 Day Moving Average: $0.96
200 Day Moving Average: $1.06
Shares Outstanding: 90251746
Valuation
Market Cap: 7.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A